Ledger.Open graph →
SEC Form D · filed July 28, 2017

BioMedomics, Inc

Offering
$2.7M
Sold
$530K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
RESEARCH TRIANGLE PARK, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

Tom Roberg · RESEARCH TRIANGLE PARK, NCDirectorLin Wu · RESEARCH TRIANGLE PARK, NCDirectorFrank Wang · RESEARCH TRIANGLE PARK, NCExec · DirectorCam Patterson · RESEARCH TRIANGLE PARK, NCDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗